Abstract
We hereby present the first descriptions of human invasive infections caused by Escherchia marmotae, a recently described species that encompasses the former “Escherichia cryptic clade V”. We report four cases, one acute sepsis of unknown origin, one post-operative sepsis after cholecystectomy, one spondylodiscitis and one upper urinary tract infection. Cases were identified through unsystematic queries in a single clinical lab during six months. Through genome sequencing of the causative strains combined with available genomes from elsewhere we demonstrate E. marmotae to be a likely ubiquitous species containing genotypic virulence traits associated with Escherichia pathogenicity. The invasive isolates were scattered among isolates from a range of non-human sources, thus indicating inherent virulence in multiple phylogenetic lineages. Pan genome analyses indicate that E. marmotae has a large accessory genome and is likely to obtain ecologically advantageous traits like genes encoding antimicrobial resistance. Reliable identification might be possible by MALDI-ToF MS, but relevant spectra are missing in commercial databases. E. marmotae can be identified through 16S rRNA sequencing. Escherichia marmotae could represent a relatively common human pathogen and improved diagnostics will provide a better understanding of its clinical importance.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by the Regional ethical committee of Western Norway (REK 322324). Written, informed consent to use clinical data was obtained from three out of four patients. For the fourth patient only microbiological data is provided.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present work are contained in the manuscript
